Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells

Journal of Dermatological Science

Volumn 51, Issue 3, 2008, Pages 181-189

  Nakai, Kozo ^a   Yoneda, Kozo ^a   Igarashi, Junsuke ^b   Moriue, Tetsuya ^a   Kosaka, Hiroaki ^b   Kubota, Yasuo ^a  

^a Department of Dermatology ^*  (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; EGF receptor; HaCaT cells; Reactive oxygen species

Indexed keywords

ANGIOTENSIN II; APOCYNIN; ARGININE METHYL ESTER; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HYDROETHIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; DOSE RESPONSE; ENZYME SYNTHESIS; EPIDERMIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANGIOTENSIN II; BASE SEQUENCE; CELL LINE; CELL PROLIFERATION; DNA PRIMERS; GENE EXPRESSION; HUMANS; KERATINOCYTES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; XANTHINE; XANTHINE OXIDASE;

EID: 48049114613     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.03.004     Document Type: Article

References (32)

1. Timmermans P.B., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45 (1993) 205-251
2. Tebbs C., Pratten M.K., and Broughton Pipkin F. Angiotensin II is a growth factor in the peri-implantation rat embryo. J Anat 195 (1999) 75-86
3. Stoll M., Steckelings U.M., Paul M., Bottari S.P., Metzger R., Unger T., et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95 (1995) 651-657
4. Yahata Y., Shirakata Y., Tokumaru S., Yang L., Dai X., Tohyama M., et al. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem 281 (2006) 13209-13216
5. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
6. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59 (2002) 1428-1459
7. Valencia A., and Kochevar I.E. Nox1-based NADPH oxidase is the major source of UVA-induced reactive oxygen species in human keratinocytes. J Invest Dermatol 128 (2008) 214-222
8. Chamulitrat W., Huber A., Riedel H.D., and Stremmel W. Nox1 induces differentiation resistance in immortalized human keratinocytes generating cells that express simple epithelial keratins. J Invest Dermatol 127 (2007) 2171-2183
9. von Montfort C., Fernau N.S., Beier J.I., Sies H., and Klotz L.O. Extracellular generation of hydrogen peroxide is responsible for activation of EGF receptor by ultraviolet A radiation. Free Radic Biol Med 41 (2006) 1478-1487
10. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J Invest Dermatol 110 (1998) 966-971
11. He Y.Y., Huang J.L., Gentry J.B., and Chignell C.F. Epidermal growth factor receptor down-regulation induced by UVA in human keratinocytes does not require the receptor kinase activity. J Biol Chem 278 (2003) 42457-42465
12. Boukamp P., Petrussevska R.T., Breitkreutz D., Hormung J., Markham A., and Fusenig N.H. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106 (1988) 761-771
13. Igarashi J., Miyoshi M., Hashimoto T., Kubota Y., and Kosaka H. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol 150 (2007) 470-479
14. Steckelings U.M., Artuc M., Paul M., Stoll M., and Henz B.M. Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor. Biochem Biophys Res Commun 229 (1996) 329-333
15. Nakai K., Kadiiska M.B., Jiang J.J., Stadler K., and Mason R.P. Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin. Proc Natl Acad Sci USA 103 (2006) 4616-4621
16. Nakai K., Fujii S., Yamamoto A., Igarashi J., Kubota Y., and Kosaka H. Effects of high glucose on NO synthesis in human keratinocyte cell line (HaCaT). J Dermatol Sci 31 (2003) 211-218
17. Kimura B., Sumners C., and Phillips M.I. Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun 187 (1992) 1083-1090
18. Takeda H., Katagata Y., Hozumi Y., and Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol 165 (2004) 1653-1662
19. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
20. Geiszt M., and Leto T.L. The Nox family of NAD(P)H oxidases: host defense and beyond. J Biol Chem 279 (2004) 51715-51718
21. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4 (2004) 181-189
22. Zielonka J., Sarna T., Roberts J.E., Wishart J.F., and Kalyanaraman B. Pulse radiolysis and steady-state analyses of the reaction between hydroethidine and superoxide and other oxidants. Arch Biochem Biophys 456 (2006) 39-47
23. Wahl M.I., and Carpenter G. Role of growth factors and their receptors in the control of normal cell proliferation and cancer. Clin Physiol Biochem 5 (1987) 130-139
24. Nakai K., Kubota Y., and Kosaka H. Inhibition of nuclear factor kappa B activation and inducible nitric oxide synthase transcription by prolonged exposure to high glucose in the human keratinocyte cell line HaCaT. Br J Dermatol 150 (2004) 640-646
25. Hsieh H.L., Sun C.C., Wu C.B., Wu C.Y., Tung W.H., Wang H.H., et al. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. J Cell Biochem 103 (2007) 1732-1746
26. Miller W.E., Cheshire J.L., Baldwin Jr. A.S., and Raab-Traub N. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene 16 (1998) 1869-1877
27. Johnson A.C., Murphy B.A., Matelis C.M., Rubinstein Y., Piebenga E.C., Akers L.M., et al. Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression. Mol Med 6 (2000) 17-27
28. Pueyo M.E., Arnal J.F., Rami J., and Michel J.B. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol 274 (1998) C214-C220
29. Bayraktutan U. Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells. J Hypertens 21 (2003) 2093-2101
30. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 (2004) 1795-1801
31. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
32. Zhang G.X., Nagai Y., Nakagawa T., Miyanaka H., Fujisawa Y., Nishiyama A., et al. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol 293 (2007) H2403-H2408